Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-14-000043
Filing Date
2014-04-21
Accepted
2014-04-21 17:08:41
Documents
6
Period of Report
2013-12-31
Effectiveness Date
2014-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A ligand-2014proxystatement.htm DEF 14A 855565
2 ligand2014proxystatem_image1.jpg GRAPHIC 9775
3 proxymeetingnotice1.jpg GRAPHIC 205515
4 proxymeetingnotice2.jpg GRAPHIC 177173
5 proxynoticecard1.jpg GRAPHIC 232591
6 proxynoticecard2.jpg GRAPHIC 104271
  Complete submission text file 0000886163-14-000043.txt   1862198
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 14774425
SIC: 2834 Pharmaceutical Preparations